Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

9.63

+0.39 (4.22%)

At close: Oct 8, 2025, 4:00 PM EDT

9.50

-0.13 (-1.35%)

After-hours: Oct 8, 2025, 4:12 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Biopharmaceutical	80.00M	Log In	Log In	Log In	Log In
Biopharmaceutical Growth	2752.05%	Log In	Log In	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	80.00M	Log In	Log In	Log In	Log In
United States Growth	2752.05%	Log In	Log In	Log In	Log In